Regulator Rejects Novartis Heart Failure Drug – Fox Business
Regulator Rejects Novartis Heart Failure Drug
Fox Business U.S. health regulators turned down an application to approve Novartis’ (NAR) experimental heart failure drug due to insufficient evidence that it improves symptoms, the Swiss drugmaker said on Friday. Novartis said in a statement the Food and Drug … US regulator rejects Novartis heart failure drugReuters FDA Rejects Novel Novartis Drug For Acute Heart FailureForbes FDA Says No to Serelaxin for Heart FailureMedPage Today |